PROANGIOGENIC COMPOSITIONS, PROCESS FOR THEIR PREPARATION AND USES THEREOF
FR2909559A1
Cellular preparations for use as agent stimulating revascularization
WO2007012764A2
Cell/ligand marking system, wherein the marker is of eph type, cell material comprising said system, method for preparing same and proangiogenetic use
US2005107296A1
Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
FR2831540A1
Isolated peptide from the hepatocyta growth factor and its variants, method of preparation and therapeutic use as antiangiogenic agents
FR2802931A1
Novel peptides, use in therapeutics and pharmaceutical compositions containing them
FR2782010A1
Use of arsenic compound as apoptotic substance for treating megakaryocytary or platelet hyperproliferative disorders
FR2774990A1
Novel peptides, use in therapeutics and pharmaceutical compositions containing them
FR2726188A1
Glycosaminoglycan / megacaryocyta growth factor composition, use in therapeutics
EP0314576A1
Tetra and pentapeptides with the sequence lysyl-arginyl-aspartyl, and their use as antithrombotics
IE882482L
Protein with vascular activity
EP0303538A2
Protein with a vascular activity, derived from monocytes and its analogues, process for its extraction and their uses as therapeutic agents and for the preparation of antibodies
